Skip to main content

Maisons du Monde: H1 2026 Results

 PRESS RELEASENantes, September 25th, 2026 H1 2026 Results: Continued cost discipline and balance sheet  restoration amidst a persistently challenging top-line environment  Reminder: since July 2026, the Group has been operating with a strengthened balance sheet following the refinancing agreement reached with its main stakeholders. Full details are available in the press release dated July 31, 2026.  Net sales reached €412.8m, down 7.1% vs LY (-5.8% LfL) in a subdued market  €15m gross savings achieved Working Capital improvementNet Sales reached €412.8m, down 7.1% YoY (-5.8% on a LfL basis):Performance contracted further in Q2 (-9.8%) compared to Q1 (-4.5%), impacted by constrained inventory levels and a deliberate scale-back of promotional activities  The store network keeps proving resilience at -3.0% LfL. Southern Europe remained...

Continue reading

WidePoint Corporation Statement Regarding GAO Protest Decision on DHS CWMS 3.0 Award

FAIRFAX, Va., Sept. 25, 2026 (GLOBE NEWSWIRE) — WidePoint Corporation (NYSE American: WYY), a leading provider of Secure Mobile Management and Managed Services Solutions, today provided an update regarding the Government Accountability Office (GAO) decision concerning the Department of Homeland Security (DHS) Cellular Wireless Managed Services (CWMS) 3.0 contract. The GAO has notified WidePoint that it has sustained the protest filed by TurningPoint Global Solutions regarding the award. It is important to note that a “sustained” protest does not necessarily conclude the procurement process; rather, it is a routine mechanism within federal contracting that may lead to various outcomes, including corrective actions or re-evaluations, as determined by the agency. In accordance with standard federal procurement procedures...

Continue reading

Orion Corporation: Acquisition of own shares during week 39, 2026

Orion Corporation: Acquisition of own shares during week 39, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The buyback programme runs from 1 September 2026 until no later than 31 December 2026, and it is executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052. Orion Corporation’s shares have been acquired as follows:Date Exchange transaction Share trading code Number of shares                      Average price/ share (EUR)* Total transaction value (EUR)September 21, 2026 Buy ORNBV   23,704 82.2724 1,950,184.97September 22, 2026 Buy ORNBV   22,639 83.2528 1,884,760.14September 23, 2026 Buy ORNBV   23,552 83.3016 1,961,919.28September 24, 2026 Buy ORNBV  ...

Continue reading

REXEL: Rexel to acquire GCG

Rexel to acquire GCG, a leading specialty infrastructure platform in the US, a key milestone on Rexel’s strategic roadmapSeizing a major opportunity to expand our US business, adding a c.$1.1bn sales specialty infrastructure platform Leveraging GCG’s exposure to high growth segments & strong value-added customer service $1.4bn Enterprise Value acquisition at an attractive

Continue reading

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it will implement a 1-for-10 reverse stock split of its issued and outstanding shares of common stock (the “Reverse Stock Split”), effective at 12:01 a.m. Eastern Time on September 29, 2026. The Reverse Stock Split was approved by the Company’s stockholders at its Annual Meeting of Stockholders held on September 18, 2026, with the final ratio, within the range approved by stockholders, subsequently determined by the Company’s board of directors. The Reverse Stock Split is intended to bring the Company into compliance with the minimum bid price requirement for continued listing on...

Continue reading

Marimekko Corporation: Repurchase of own shares during week 39/2026

Marimekko Corporation, Stock Exchange Release, 25 September 2026 at 6.45 p.m. EEST Marimekko Corporation: Repurchase of own shares during week 39/2026 Marimekko Corporation has acquired its own shares during week 39 in the Helsinki Stock Exchange as follows:Trade date Shares Average price / share Total cost21.9.2026 12,700 9.5713 121,555.5122.9.2026 12,442 9.6475 120,034.2023.9.2026 11,788 9.6018 113,186.0224.9.2026 12,296 9.5415 117,322.2825.9.2026 13,800 9.5130 131,279.40Total amount, week 39 63,026 9.5735 603,377.41Marimekko Corporation now holds a total of 196,486 shares including the shares repurchased on 25 September 2026.        On 14 September 2026, Marimekko announced that it will start acquiring the company’s own shares based on the authorization granted by the Annual General Meeting held on 16 April 2026....

Continue reading

Participation notification by Citigroup Inc.

Press release  –  Regulated information Brussels, September 25, 2026, 17:45 CEST In line with Belgian transparency legislation (Law of May 2, 2007), Citigroup Inc. recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%. Here is a summary of the notification:Date on which the threshold is crossed Voting rights after the transaction Equivalent financial instruments after the transaction TotalSeptember 21, 2026 – – –The notification, dated September 22, 2026, contains the following information:Reason for the notification:Acquisition or disposal of voting securities or voting rights Downward crossing of the lowest thresholdNotified by: A parent undertaking or a controlling person Date on which the threshold is crossed: September 21, 2026 Threshold...

Continue reading

Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study

Ad hoc announcement pursuant to Art. 53 LR U.S. clinical hold remains in place; study continues in all other countries Company initiates expansion of clinical sites and enrollment in Europe, Asia and Latin America Topline data from ENIGMA-TRS 1 expected in Q1 2027 MILAN and MORRISTOWN, N.J., Sept. 25, 2026 (GLOBE NEWSWIRE) — Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced that it has been informed by the U.S. Food and Drug Administration (FDA) that the hold on the enrollment of new patients will remain in place at U.S. sites in the Phase 3 ENIGMA-TRS 2 study with evenamide. Enrollment in the study continues outside the U.S. Newron anticipates receiving...

Continue reading

Pinnacle Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 25, 2026

Palm Beach, FL, Sept. 25, 2026 (GLOBE NEWSWIRE) — Pinnacle Acquisition Corporation (NYSE: PNAQ.U) (the “Company”) announced today that, commencing September 25, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and rights included in the units. The Class A ordinary shares and rights that are separated will trade on the New York Stock Exchange under the symbols “PNAQ” and “PNAQ.RT,” respectively. Those units not separated will continue to trade on the New York Stock Exchange under the symbol “PNAQ.U.” “We believe our team’s experience building and scaling public-market platforms, executing strategic M&A and working across commercial and consumer finance positions us well to identify an exceptional company and help accelerate its next...

Continue reading

AMG Critical Materials N.V. Publishes Annex IX Information Document ahead of Listing on the Frankfurt Stock Exchange

Amsterdam, 25 September 2026 — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) has published an Annex IX information document in connection with the secondary listing of its shares on the Frankfurt Stock Exchange pursuant to Article 1(5)(ba) of Regulation (EU) 2017/1129 (the Prospectus Regulation). The intention to apply for the listing on the Frankfurt Stock Exchange was announced on August 24, 2026. The first day of trading on the Frankfurt Stock Exchange is expected to be September 30, 2026. The AMG shares will trade on the Frankfurt Stock Exchange under the ticker symbol “ADG”. As previously announced, AMG does not plan to issue or offer any new shares in connection with the secondary listing in Frankfurt. Euronext Amsterdam will continue to be AMG’s primary listing. The Annex IX information document was also filed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.